[T1期非小细胞肺癌患者纵隔淋巴结转移及淋巴结清扫范围的研究进展]
[Advances of mediastinal lymph node metastasis and the extent of lymph node dissection in patients with stage T1 non-small cell lung cancer].
作者信息
Ding Ningning, Mao Yousheng
机构信息
Department of Thoracic Surgery, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2015 Jan;18(1):34-41. doi: 10.3779/j.issn.1009-3419.2015.01.06.
Abstract
Lung cancer ranks the first position in morbidity and mortality among all malignances in China. Non-small cell lung cancer (NSCLC) accounts for nearly 80% of all lung malignancies. Surgical resection is still the current major treatment method for early stage NSCLC. Lymph node stages together with the extent of lymph node dissection directly affect the prognosis. The site of primary lung carcinoma may affect the route and status of lymph node metastasis. Up to now, anatomical lobectomy and mediastinal lymph node dissection is deemed to be the standard surgical treatment for NSCLC. However, it is still controversial in the extent of lymph node dissection for T1 NSCLC. More and more surgeons intend to perform selective mediastinal lymph node dissection instead of complete mediastinal lymph node dissection for T1 NSCLC in recent years.
摘要
在中国，肺癌的发病率和死亡率在所有恶性肿瘤中位居首位。非小细胞肺癌（NSCLC）占所有肺部恶性肿瘤的近80%。手术切除仍是目前早期NSCLC的主要治疗方法。淋巴结分期以及淋巴结清扫范围直接影响预后。原发性肺癌的部位可能影响淋巴结转移的途径和状态。迄今为止，解剖性肺叶切除术和纵隔淋巴结清扫术被认为是NSCLC的标准外科治疗方法。然而，对于T1期NSCLC的淋巴结清扫范围仍存在争议。近年来，越来越多的外科医生倾向于对T1期NSCLC行选择性纵隔淋巴结清扫而非完全性纵隔淋巴结清扫。
相似文献
1
[Advances of mediastinal lymph node metastasis and the extent of lymph node
dissection in patients with stage T1 non-small cell lung cancer].[T1期非小细胞肺癌患者纵隔淋巴结转移及淋巴结清扫范围的研究进展]
Zhongguo Fei Ai Za Zhi. 2015 Jan;18(1):34-41. doi: 10.3779/j.issn.1009-3419.2015.01.06.
2
[Advances in Lymph Node Metastasis and the Modes of Lymph Node
Dissection in Early Stage Non-small Cell Lung Caner].[早期非小细胞肺癌淋巴结转移及淋巴结清扫方式的研究进展]
Zhongguo Fei Ai Za Zhi. 2016 Jun 20;19(6):359-63. doi: 10.3779/j.issn.1009-3419.2016.06.12.
3
Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.临床I期非小细胞肺癌患者纵隔淋巴结站的切除范围：对预后的影响。
Thorac Cardiovasc Surg. 2014 Oct;62(7):599-604. doi: 10.1055/s-0033-1360478. Epub 2014 Jan 13.
4
[Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].[临床I a期非小细胞肺癌淋巴结清扫的适宜范围]
Ai Zheng. 2007 Mar;26(3):303-6.
5
Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection.Ⅰ期非小细胞肺癌患者纵隔淋巴结受累：合理淋巴结清扫术的可能性。
J Thorac Oncol. 2015 Jun;10(6):930-6. doi: 10.1097/JTO.0000000000000546.
6
Surgical treatment of non-small cell lung cancer: mediastinal lymph node dissection.非小细胞肺癌的外科治疗：纵隔淋巴结清扫术
Rays. 2004 Oct-Dec;29(4):423-9.
7
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.氟-18 氟代脱氧葡萄糖标准摄取值对临床Ⅰ a 期非小细胞肺癌系统淋巴结清扫或采样的更好选择的预测价值。
Clin Lung Cancer. 2013 Sep;14(5):568-73. doi: 10.1016/j.cllc.2013.02.002. Epub 2013 Jul 5.
8
Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.非小细胞肺癌完全切除术后纵隔淋巴结清扫与系统采样后的发病率、生存率及复发部位
Ann Thorac Surg. 2005 Jul;80(1):268-74; discussion 274-5. doi: 10.1016/j.athoracsur.2005.02.005.
9
Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.前哨淋巴结取样限制了I期非小细胞肺癌的淋巴结清扫术。
Eur J Cardiothorac Surg. 2007 Aug;32(2):356-61. doi: 10.1016/j.ejcts.2007.04.030. Epub 2007 May 21.
10
In vivo identification of sentinel lymph nodes for clinical stage I non-small cell lung cancer for abbreviation of mediastinal lymph node dissection.对临床I期非小细胞肺癌前哨淋巴结进行体内识别以简化纵隔淋巴结清扫术。
Lung Cancer. 2004 Oct;46(1):49-55. doi: 10.1016/j.lungcan.2004.03.008.
引用本文的文献
1
Lobe-Specific Node Dissection Can Be a Suitable Alternative to Systematic Lymph Node Dissection in Highly Selective Early-Stage Non-Small-Cell Lung Cancer Patients: A Meta-Analysis.肺段特异性淋巴结清扫术在高度选择性早期非小细胞肺癌患者中可以替代系统性淋巴结清扫术：一项荟萃分析。
Ann Thorac Cardiovasc Surg. 2021 Jun 20;27(3):143-150. doi: 10.5761/atcs.oa.20-00136. Epub 2020 Dec 7.
本文引用的文献
1
Comparison of lobe-specific mediastinal lymphadenectomy versus systematic mediastinal lymphadenectomy for clinical stage T₁a N₀ M₀ non-small cell lung cancer.临床分期为T₁a N₀ M₀的非小细胞肺癌行肺叶特异性纵隔淋巴结清扫术与系统性纵隔淋巴结清扫术的比较
J Cancer Res Ther. 2013 Sep;9 Suppl 2:S101-5. doi: 10.4103/0973-1482.119119.
2
Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.比较三种 CT 测量方法在预测临床Ⅰ期非小细胞肺癌患者低侵袭性方面的价值。
Ann Thorac Surg. 2013 Jun;95(6):1878-84. doi: 10.1016/j.athoracsur.2013.02.022. Epub 2013 Apr 22.
3
Feasibility of cytological diagnosis of sarcoidosis with endobronchial US-guided transbronchial aspiration.经支气管超声引导下经支气管针吸活检进行结节病细胞学诊断的可行性
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):82-9.
4
Rapid on-site evaluation and low registration error enhance the success of electromagnetic navigation bronchoscopy.快速现场评估和低注册错误率提高了电磁导航支气管镜检查的成功率。
Ann Thorac Med. 2013 Jan;8(1):28-32. doi: 10.4103/1817-1737.105716.
5
Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.经支气管超声引导针吸活检术标本对非小细胞肺癌分型的充分性。
Lung Cancer. 2013 Apr;80(1):30-4. doi: 10.1016/j.lungcan.2012.12.017. Epub 2013 Jan 10.
6
A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.一项对比经支气管超声引导针吸活检术与纵隔镜检查术用于肺癌纵隔淋巴结分期的前瞻性对照临床试验。
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1393-400.e1. doi: 10.1016/j.jtcvs.2011.08.037. Epub 2011 Oct 2.
7
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.正电子发射断层扫描-计算机断层扫描与侵袭性纵隔分期在非小细胞肺癌中的比较：早期肺正电子发射断层扫描试验纵隔分期结果。
J Thorac Oncol. 2011 Aug;6(8):1367-72. doi: 10.1097/JTO.0b013e318220c912.
8
The new tumor, node, and metastasis staging system.新的肿瘤、淋巴结和转移分期系统。
Semin Respir Crit Care Med. 2011 Feb;32(1):44-51. doi: 10.1055/s-0031-1272868. Epub 2011 Apr 15.
9
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.随机对照试验：在 N0 或 N1（肺门淋巴结转移阴性）非小细胞肺癌患者的肺切除术中，纵隔淋巴结采样与完全淋巴结清扫的比较：美国外科医师学院肿瘤学组 Z0030 试验结果。
J Thorac Cardiovasc Surg. 2011 Mar;141(3):662-70. doi: 10.1016/j.jtcvs.2010.11.008.
10
[Estimation and projection of lung cancer incidence and mortality in China].[中国肺癌发病率与死亡率的估计及预测]
Zhongguo Fei Ai Za Zhi. 2010 May;13(5):488-93. doi: 10.3779/j.issn.1009-3419.2010.05.20.
Zotero 插件